Page last updated: 2024-08-24

isoguanosine and Leukemia, Myeloid, Acute

isoguanosine has been researched along with Leukemia, Myeloid, Acute in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cui, S; Gao, C; Liu, P; Liu, Z; Ma, C; Tan, X; Xu, R	1

Other Studies

1 other study(ies) available for isoguanosine and Leukemia, Myeloid, Acute

Article	Year
The Identification of APOBEC3G as a Potential Prognostic Biomarker in Acute Myeloid Leukemia and a Possible Drug Target for Crotonoside. Molecules (Basel, Switzerland), 2022, Sep-07, Volume: 27, Issue:18 Topics: Adenosine; APOBEC-1 Deaminase; APOBEC-3G Deaminase; Biological Products; Biomarkers; Cytidine Deaminase; Cytosine; Guanosine; HIV-1; Humans; Leukemia, Myeloid, Acute; Molecular Docking Simulation; Prognosis; RNA; Uracil	2022

Article

Year

The Identification of APOBEC3G as a Potential Prognostic Biomarker in Acute Myeloid Leukemia and a Possible Drug Target for Crotonoside.

Molecules (Basel, Switzerland), 2022, Sep-07, Volume: 27, Issue:18

Topics: Adenosine; APOBEC-1 Deaminase; APOBEC-3G Deaminase; Biological Products; Biomarkers; Cytidine Deaminase; Cytosine; Guanosine; HIV-1; Humans; Leukemia, Myeloid, Acute; Molecular Docking Simulation; Prognosis; RNA; Uracil

2022